UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021484 |
|---|---|
| Receipt number | R000024781 |
| Scientific Title | Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma |
| Date of disclosure of the study information | 2016/04/01 |
| Last modified on | 2022/09/19 12:06:36 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/03/15 21:51:13 | ||
| 2 | Update | 2016/09/09 20:41:57 | Recruitment status |
|
| 3 | Update | 2018/09/17 15:00:03 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Name of primary person or sponsor Organization |
|
| 4 | Update | 2020/11/20 12:21:38 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Email3 Organization Organization Address Address Tel |
|
| 5 | Update | 2020/11/20 12:24:02 | Key secondary outcomes |
|
| 6 | Update | 2021/07/20 23:05:38 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 7 | Update | 2022/03/22 22:19:30 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 8 | Update | 2022/09/19 12:06:36 | URL releasing protocol Number of participants that the trial has enrolled |
